TrialThe British journal of ophthalmology2017

Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study.

Eydie Miller Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.